Perceptions of Barriers Preventing the Initiation and Utilization of Continuous Glucose Monitors Among Adults With Type 2 Diabetes

Abstract

Get full access to this article

View all access options for this article.

References

Moore

Medicare expands coverage of continuous glucose monitoring. 2023. https://www.aafp.org/pubs/fpm/blogs/gettingpaid/entry/medicare-cgm-expansion.html

Beck

Riddlesworth

Ruedy

, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA. 2017;317:371-378. doi:10.1001/jama.2016.19975

Riddlesworth

Price

Cohen

Beck

RW.

Hypoglycemic event frequency and the effect of continuous glucose monitoring in adults with type 1 diabetes using multiple daily insulin injections. Diabetes Ther. 2017;8:947-951. doi:10.1007/s13300-017-0281-4

Pratley

Kanapka

Rickels

, et al. Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. JAMA. 2020;323:2397-2406. doi:10.1001/jama.2020.6928

Heinemann

Freckmann

Ehrmann

, et al. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Lancet. 2018;391:1367-1377. doi:10.1016/S0140-6736(18)30297-6

El Sayed

Aleppo

Aroda

, et al. 7. Diabetes Technology: Standards of Care in Diabetes—2023. Diabetes Care. 2023;46 (suppl 1):S111-S127. doi:10.2337/dc23-S007

Beck

Riddlesworth

Ruedy

, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. 2017;167:365-374. doi:10.7326/M16-2855

Martens

Beck

Bailey

, et al. Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. JAMA. 2021;325(22):2262-2272. doi:10.1001/jama.2021.7444.

Mayberry

Hendrickson

McCoy

Elasy

TA.

62-LB: rapid CGM uptake among adults with type 2 diabetes. Diabetes. 2022;71(suppl 1):62-LB. doi:10.2337/db22-62-LB

10.

Lanning

Tanenbaum

Wong

Hood

KK.

Barriers to continuous glucose monitoring in people with type 1 diabetes: clinician perspectives. Diabetes Spectr. 2020;33(4):324-330. doi:10.2337/ds19-0039

11.

Qualtrics. Qualtrics. Published 2024. https://www.qualtrics.com

12.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring. Diabetes Technol Ther. 2010;12(9):679-684. doi:10.1089/dia.2010.0015

13.

Peyyety

Zupa

Vajravelu

, et al. Barriers and facilitators to uptake of continuous glucose monitoring for management of type 2 diabetes mellitus in youth. Sci Diabetes Self Manag Care. 2023;49(6):426-437. doi:10.1177/26350106231205030

14.

danatech CGM (& insulin delivery device) Affordability programs. https://www.adces.org/education/danatech/glucose-monitoring/continuous-glucose-monitors-(cgm)/cgm-affordability-programs. Accessed June 12, 2025.